Add to ORKGAlthough major progress has been made in the prevention of CMV disease after hematopoietic cell transplantation (HCT), specific problems remain and available antiviral agents are associated with major toxicities. This article reviews current aspects of CMV diagnosis, prevention, and treatment in HCT recipients and defines areas of unmet medical need
Cytomegalovirus (CMV) continues to be a cause of substantial morbidity and death after solid-organ t...
Prevention of cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation (HSCT) g...
BACKGROUND: Cytomegalovirus (CMV) infection of solid organ transplant (SOT) recipients causes both '...
Cytomegalovirus (CMV) continues to cause major complications after hematopoietic cell transplantatio...
Cytomegalovirus (CMV) continues to be a cause of substantial morbidity and death after solid-organ t...
Cytomegalovirus (CMV) infection continues to be a problem in selected populations following hemato-p...
Due to its negative impact in the outcome of stem cell transplant (SCT) and solid organ transplant p...
The article presents an analysis of the current state of the problem antiviral therapy CMV-infection...
Cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation (HSCT) is one of the c...
Since the start of treatment with allogeneic haematopoietic stem cell transplantation (SCT), cytomeg...
Cytomegalovirus (CMV) infection takes an important place as a major cause of morbidity and mortality...
Cytomegalovirus (CMV) infection remains a significant infectious complication after transplantation....
Introduction: Cytomegalovirus (CMV) still causes significant morbidity and mortality in patients giv...
AbstractCytomegalovirus (CMV) infection is a major cause of morbidity and mortality after hematopoie...
In the last decade, transplantology has become the treatment of choice for a large number of maligna...
Cytomegalovirus (CMV) continues to be a cause of substantial morbidity and death after solid-organ t...
Prevention of cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation (HSCT) g...
BACKGROUND: Cytomegalovirus (CMV) infection of solid organ transplant (SOT) recipients causes both '...
Cytomegalovirus (CMV) continues to cause major complications after hematopoietic cell transplantatio...
Cytomegalovirus (CMV) continues to be a cause of substantial morbidity and death after solid-organ t...
Cytomegalovirus (CMV) infection continues to be a problem in selected populations following hemato-p...
Due to its negative impact in the outcome of stem cell transplant (SCT) and solid organ transplant p...
The article presents an analysis of the current state of the problem antiviral therapy CMV-infection...
Cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation (HSCT) is one of the c...
Since the start of treatment with allogeneic haematopoietic stem cell transplantation (SCT), cytomeg...
Cytomegalovirus (CMV) infection takes an important place as a major cause of morbidity and mortality...
Cytomegalovirus (CMV) infection remains a significant infectious complication after transplantation....
Introduction: Cytomegalovirus (CMV) still causes significant morbidity and mortality in patients giv...
AbstractCytomegalovirus (CMV) infection is a major cause of morbidity and mortality after hematopoie...
In the last decade, transplantology has become the treatment of choice for a large number of maligna...
Cytomegalovirus (CMV) continues to be a cause of substantial morbidity and death after solid-organ t...
Prevention of cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation (HSCT) g...
BACKGROUND: Cytomegalovirus (CMV) infection of solid organ transplant (SOT) recipients causes both '...